About Dr. Ashok Kumar Vaid
Dr. Ashok Kumar Vaid is a leading medical oncologist and hematologist with over 40 years of experience. Specializing in blood cancers, solid tumors, and stem cell transplantation, Dr. Vaid pioneered North India’s private sector bone marrow transplant program. A Padma Shri awardee, he has led over 40 clinical research studies and published extensively. His patient-centered approach emphasizes empathy, precision oncology, and cutting-edge treatments like immunotherapy. International patients benefit from virtual consultations, language support, and travel assistance through Cancer Rounds for seamless care access.
OPD Schedule Of Dr. Ashok Kumar Vaid
Consultation Fees Rs. /-
Medanta - The Medicity, Gurgaon
- MBBS – Government Medical College, Jammu.
- MD (Internal Medicine) – Government Medical College, Jammu.
- DM (Medical Oncology) – Dr. M.G.R. Medical University, Chennai.
- Blood Cancers: Leukemia, Lymphoma.
- Solid Tumors: Breast, Lung, Gastrointestinal, Skin, and Brain Cancers.
- Precision Oncology
- Immunotherapy
- Cancer Genomics
- Bone Marrow Transplantation: Autologous, Allogeneic, Haploidentical, and Unrelated Donor Transplants.
- Stem Cell Transplantation
- Chairman – Medical Oncology and Hematology, Medanta – The Medicity, Gurugram.
- Head of Department – Medical Oncology, Artemis Health Institute, Gurugram.
- Senior Consultant – Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi.
- Consultant Oncologist & Faculty – Internal Medicine, Government Medical College, Jammu.
- Principal Investigator – Over 40 international and national clinical research studies.
- Postgraduate Teacher – Registered with the National Board of Examinations.
- University Examiner – Super-specialty course in Medical Oncology.
- Pioneered one of the largest Stem Cell Transplant programs in North India’s private sector.
- Performed the first 25 bone marrow transplants in a private hospital in North India.
- Padma Shri Award (2009) – Conferred by the President of India for outstanding contributions to medicine.
- Chikitsa Shiromani Award (2007).
- “Prognostic Factors in Early Stage Non-Small Cell Lung Carcinoma” – Indian Journal of Medical & Pediatric Oncology, 1999.
- “Flagellate Hyperpigmentation from Bleomycin” – Indian Journal of Dermatology, Venereology, and Leprology, 2004.
- “Hodgkin’s Disease: Risk Stratification and Multidisciplinary Treatment” – JK Science, 2005.
- Contributed chapters on oncology in various medical textbooks.
- Actively involved in multiple clinical trials focusing on innovative cancer treatments.
- Services available in English, Hindi, and other languages as needed.
- Dedicated team to assist international patients with visa applications and travel arrangements.
- Offers virtual consultations to discuss treatment options before patients travel for care.
Frequently Asked Questions (FAQs):
1. How do I book an appointment with Dr. Vaid?You can book an appointment with Dr. Vaid at Medanta, Gurgaon through Cancer Rounds.2. What documents are required for a second opinion?Relevant medical records, diagnostic reports, and a summary of previous treatments are required.3. What is Dr. Vaid’s success rate in treating blood cancers?Dr. Vaid has a high success rate, particularly noted for his expertise in bone marrow transplants and hematologic malignancies.- Dr. Vaid is credited with performing the first 25 bone marrow transplants in the private sector in North India.
- Arun Kumar Chattopadhyay expressed gratitude for Dr. Vaid’s treatment of lymphoma, noting his expertise and the time taken to explain each part of the treatment.
- Anshuma Chaturvedi strongly recommended Dr. Vaid, indicating a high level of satisfaction with his care.
- Patient-Centred Care: Dr. Vaid emphasizes empathy, open communication, and shared decision-making in his approach to patient care, ensuring that each treatment plan is according to the individual’s needs and preferences.
- Technology & Innovation: He integrates the latest technologies and innovative treatment options, such as immunotherapy and precision oncology, to improve patient outcomes and advance the field of oncology.